Multilevel Analysis of MYC and BCL2 Aberrations in Diffuse Large B-Cell Lymphoma: Identifying a High-Risk Patient Subgroup Across Cell-of-Origin Using Targeted Sequencing.
Saved in:
| Title: | Multilevel Analysis of MYC and BCL2 Aberrations in Diffuse Large B-Cell Lymphoma: Identifying a High-Risk Patient Subgroup Across Cell-of-Origin Using Targeted Sequencing. |
|---|---|
| Authors: | Vimalathas G; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Haematology-Pathology Research Laboratory, Research Unit for Haematology and Research Unit for Pathology, University of Southern Denmark and Odense University Hospital, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark., Lang CS; Department of Pathology, Odense University Hospital, Odense, Denmark., Green TM; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark., Møller MB; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Haematology-Pathology Research Laboratory, Research Unit for Haematology and Research Unit for Pathology, University of Southern Denmark and Odense University Hospital, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark., Nyvold CG; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Haematology-Pathology Research Laboratory, Research Unit for Haematology and Research Unit for Pathology, University of Southern Denmark and Odense University Hospital, Odense, Denmark.; Department of Haematology, Odense University Hospital, Odense, Denmark.; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Odense University Hospital, Odense, Denmark.; Odense Patient Data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark., Hansen MH; Haematology-Pathology Research Laboratory, Research Unit for Haematology and Research Unit for Pathology, University of Southern Denmark and Odense University Hospital, Odense, Denmark.; Department of Haematology, Odense University Hospital, Odense, Denmark.; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Odense University Hospital, Odense, Denmark., Larsen TS; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Haematology-Pathology Research Laboratory, Research Unit for Haematology and Research Unit for Pathology, University of Southern Denmark and Odense University Hospital, Odense, Denmark.; Department of Haematology, Odense University Hospital, Odense, Denmark.; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Odense University Hospital, Odense, Denmark. |
| Source: | European journal of haematology [Eur J Haematol] 2025 Mar; Vol. 114 (3), pp. 469-480. Date of Electronic Publication: 2024 Nov 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1600-0609 |
|---|---|
| DOI: | 10.1111/ejh.14345 |
